Moreover, a greater number of APPL1-TβRI-ICD complexes were detected in sections from aggressive human prostate cancer tissues compared with less aggressive tumours, suggesting that increased expression of APPL1 could provoke alternative TGFβ signalling routes resulting in cancer progression. The gene discussed is TGFB1; the disease is prostate carcinoma.